These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25337585)

  • 1. Kaempferol Downregulates Insulin-like Growth Factor-I Receptor and ErbB3 Signaling in HT-29 Human Colon Cancer Cells.
    Lee HS; Cho HJ; Kwon GT; Park JH
    J Cancer Prev; 2014 Sep; 19(3):161-9. PubMed ID: 25337585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells.
    Lim DY; Cho HJ; Kim J; Nho CW; Lee KW; Park JH
    BMC Gastroenterol; 2012 Jan; 12():9. PubMed ID: 22269172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
    Kim IH; Nam TJ
    Oncol Rep; 2018 Mar; 39(3):1516-1522. PubMed ID: 29328495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells.
    Cho HJ; Kim WK; Jung JI; Kim EJ; Lim SS; Kwon DY; Park JH
    World J Gastroenterol; 2005 Sep; 11(33):5142-50. PubMed ID: 16127743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
    Kim EJ; Shin HK; Park JH
    J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
    Kim EJ; Kang IJ; Cho HJ; Kim WK; Ha YL; Park JH
    J Nutr; 2003 Aug; 133(8):2675-81. PubMed ID: 12888657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer.
    Yonezawa M; Wada K; Tatsuguchi A; Akamatsu T; Gudis K; Seo T; Mitsui K; Nagata K; Tanaka S; Fujimori S; Sakamoto C
    Digestion; 2009; 80(4):215-25. PubMed ID: 19797898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells.
    Jung JI; Chung E; Seon MR; Shin HK; Kim EJ; Lim SS; Chung WY; Park KK; Park JH
    Biofactors; 2006; 28(3-4):159-68. PubMed ID: 17473376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-10,cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells.
    Jung JI; Cho HJ; Kim J; Kwon DY; Park JH
    J Med Food; 2010 Feb; 13(1):13-9. PubMed ID: 20136431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line.
    Cho HJ; Kim WK; Kim EJ; Jung KC; Park S; Lee HS; Tyner AL; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G996-1005. PubMed ID: 12571082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M; Grijalva R; Yu D
    Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation.
    Avram D; Ranta F; Hennige AM; Berchtold S; Hopp S; Häring HU; Lang F; Ullrich S
    Cell Physiol Biochem; 2008; 21(5-6):455-62. PubMed ID: 18453753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.
    Zhou W; Rowitz BM; Dailey MJ
    Exp Biol Med (Maywood); 2018 Jul; 243(11):911-916. PubMed ID: 29950119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaempferol Induces Cell Cycle Arrest in HT-29 Human Colon Cancer Cells.
    Cho HJ; Park JH
    J Cancer Prev; 2013 Sep; 18(3):257-63. PubMed ID: 25337553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway.
    Subramaniam S; Shahani N; Strelau J; Laliberté C; Brandt R; Kaplan D; Unsicker K
    J Neurosci; 2005 Mar; 25(11):2838-52. PubMed ID: 15772344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.